FDA clears investigational new drug application of aramchol to treat NASH

  • July 23, 2014

The FDA has granted clearance to an investigational new drug application for aramchol to be used in clinical trials to treat nonalcoholic steatohepatitis, according to a press release from Galmed Pharmaceuticals.

Aramchol, a combination of cholic and arachidic acids, is a first in class member of a novel family of synthetic fatty-acid / bile-acid conjugates, according to the release.

Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More »
More »
  • Financial Planning
  • RUDZINSKI COLUMN
  • Advice for physicians
  • Be aware of important 2014 IRA updates. Analysis by Certified Financial Planner Ken Rudzinski.
More »
More »
HCV Next